James Briley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James Briley has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- William Guo
Department of Dermatology, Stony Brook University Hospital, Stony Brook, NY, United States
2 shared publications - Daniel Lozeau
Department of Dermatology, Stony Brook University Hospital, 1320 Stony Brook Road, Building F Suite 200, Stony Brook, NY, 11790, United States, 1 (631) 444-4200
1 shared publication - Dennis Chu
Renaissance School of Medicine at Stony Brook University, Stony Brook, USA
1 shared publication - Devin Miller
Department of Dermatology, Stony Brook University Hospital, 1320 Stony Brook Road, Building F Suite 200, Stony Brook, NY, 11790, United States, 1 (631) 444-4200
1 shared publication - Jay Patel
Department of Dermatology, Stony Brook University Hospital, 1320 Stony Brook Road, Building F Suite 200, Stony Brook, NY, 11790, United States, 1 (631) 444-4200
1 shared publication Katelyn Tao
Stony Brook University Stony Brook New York USA
1 shared publication
Latest Publications
- Open Access
- 16 September 2025
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 8 (1) , e77714
Acral Persistent Papular Mucinosis in the United States: Case Series and Literature Review
Background: Acral persistent papular mucinosis (APPM) is a localized variant of lichen myxedematosus (LM) characterized by asymptomatic, flesh-colored papules primarily distributed on the hands and forearms. This chronic dermatosis, distinct from generalized mucinosis due to its lack of systemic involvement, remains underreported in medical literature. Objective: In this study, we present two cases of APPM to the limited pool of documented cases in the United States, highlighting its emerging recognition. Methods: This is a case series of two patients presenting with asymptomatic papular eruptions on the hands and wrists, consistent with the typical presentation of APPM. Diagnostic confirmation via biopsy revealed focal cutaneous mucinosis. Comprehensive laboratory evaluations, including serum and urine protein electrophoresis, showed no evidence of underlying gammopathy in either patient. Results: Treatment modalities for APPM are limited and often ineffective. Unlike other forms of LM, APPM features are confined to skin lesions, posing primarily as a cosmetic concern with a favorable prognosis. Accurate diagnosis of this localized LM is crucial to differentiate it from the more severe, generalized form, scleromyxedema, which can have organ involvement and may become fatal. Notably, while spontaneous resolution is reported in LM, including discrete papular mucinosis, APPM typically persists without resolution even after extended follow-up. Conclusions: These cases underscore the importance of recognizing APPM and advocating for broader awareness and exploration of its clinical variability, etiology, and management strategies. With increasing recognition, the understanding of APPM can be enhanced, paving the way for optimized management and improved outcomes for affected individuals.
- 16 September 2025
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 8 (1) , e77714
Open AccessAcral Persistent Papular Mucinosis in the United States: Case Series and Literature Review
Background: Acral persistent papular mucinosis (APPM) is a localized variant of lichen myxedematosus (LM) characterized by asymptomatic, flesh-colored papules primarily distributed on the hands and forearms. This chronic dermatosis, distinct from generalized mucinosis due to its lack of systemic involvement, remains underreported in medical literature. Objective: In this study, we present two cases of APPM to the limited pool of documented cases in the United States, highlighting its emerging recognition. Methods: This is a case series of two patients presenting with asymptomatic papular eruptions on the hands and wrists, consistent with the typical presentation of APPM. Diagnostic confirmation via biopsy revealed focal cutaneous mucinosis. Comprehensive laboratory evaluations, including serum and urine protein electrophoresis, showed no evidence of underlying gammopathy in either patient. Results: Treatment modalities for APPM are limited and often ineffective. Unlike other forms of LM, APPM features are confined to skin lesions, posing primarily as a cosmetic concern with a favorable prognosis. Accurate diagnosis of this localized LM is crucial to differentiate it from the more severe, generalized form, scleromyxedema, which can have organ involvement and may become fatal. Notably, while spontaneous resolution is reported in LM, including discrete papular mucinosis, APPM typically persists without resolution even after extended follow-up. Conclusions: These cases underscore the importance of recognizing APPM and advocating for broader awareness and exploration of its clinical variability, etiology, and management strategies. With increasing recognition, the understanding of APPM can be enhanced, paving the way for optimized management and improved outcomes for affected individuals.
- 1 September 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (4) , 819-821
Effect of Dupilumab Therapy on Patch Test Results for Atopic Contact Dermatitis: A Systematic Review
- 1 September 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (4) , 819-821
Effect of Dupilumab Therapy on Patch Test Results for Atopic Contact Dermatitis: A Systematic Review